Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- PNAS: Phase separation of the oncogenic fusion protein EWS::FLI1 is modulated by its DNA-binding domain (Libich & Bishop Labs)
- Nature Communications: Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory. (Rao, Sung, & Chen Labs)
- Cell Reports: Distinct roles of the two BRCA2 DNA-binding domains in DNA damage repair and replication fork preservation (Sung, Libich Labs)
- Trends in Molecular Medicine: The RB protein: more than a sentry of cell cycle entry (Sung Lab)
- Nature Communications: Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory (Rao, Chen, Zheng, Sung Labs et al)
Events
4th Annual Gear Up Against Kids Cancer Bike Ride
We’re excited to announce that the 4th Annual Gear Up Against Kids Cancer has been rescheduled for Saturday, October 18, 2025, at a new location: Floresville City Park (756 TX-97, Floresville, TX 78114), right next to the Event Center.